• Citer

Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapy.

par Rosiere, Rémi ;Van Woensel, Matthias ;Mathieu, Véronique ;Langer, Ingrid ;Mathivet, Thomas;Vermeersch, Marjorie ;Amighi, Karim ;Wauthoz, Nathalie
Référence International journal of pharmaceutics
Publication Publié, 2016-02

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapy.
Auteur:	Rosiere, Rémi; Van Woensel, Matthias; Mathieu, Véronique; Langer, Ingrid; Mathivet, Thomas; Vermeersch, Marjorie; Amighi, Karim; Wauthoz, Nathalie
Informations sur la publication:	International journal of pharmaceutics
Statut de publication:	Publié, 2016-02
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	3,3′-Dioctadecyloxacarbocyanine perchlorate (PubChem CID: 2762625)
	dextran (PubChem CID: 71315856)
	dry powder for inhalation
	ethylene glycol (PubChem CID: 174)
	folate
	folic acid (PubChem CID: 6037)
	inhaled chemotherapy
	leucine (PubChem CID: 6106)
	lung cancer
	mannitol (PubChem CID: 6251)
	micelle
	paclitaxel
	paclitaxel (PubChem CID: 36314)
	stearic acid (PubChem CID: 5281)
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0378-5173
	info:doi/10.1016/j.ijpharm.2016.01.073
	info:pii/S0378-5173(16)30074-6
	info:scp/84957600206
	info:pmid/26850313